Cosacthen 0.25 mg/ml solution for injection for dogs
Cosacthen 0.25 mg/ml solution for injection for dogs
Authorised
- Tetracosactide hexaacetate
Product identification
Medicine name:
Cosacthen 0.25 mg/ml solution for injection for dogs
COSACTHEN 0,25 MG/ML ενέσιμο διάλυμα για σκύλους
Active substance:
- Tetracosactide hexaacetate
Target species:
-
Dog
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Tetracosactide hexaacetate0.28/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Dog
-
Intravenous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH01AA02
Legal status of supply:
-
Medicinal product subject to medical prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Type I clear glass vial with a coated rubber stopper and aluminium seal packed in a cardboard box. Pack size: 1 ml vial per box.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Eurovet Animal Health B.V.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 37109/27-03-2020/K-0238101
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0461/001
Concerned member states:
-
Austria
-
Belgium
-
Croatia
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Italy
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
